SLSG Blog

Our blog will keep you informed of all the latest news and developments in the growing CBD industry. Alongside articles from the news, we will also keep you updated about what’s happening at Swiss Life Sciences Group.

The hands of scientists dropping marijuana oil for experimentation and research, ecological hemp plant herbal pharmaceutical cbd oil from a jar.

Swiss Life Sciences Group Launches RawSwiss Lifestyle Brand

13. 9. 2021
Swiss Life Sciences Group (SLSG) continues its expansion in the CBD marketplace and is proud to announce the launch of its RawSwiss CBD lifestyle brand. ...Read More
pexels-chokniti-khongchum-2280571-min

UK Government Vows To Make UK Life Sciences Superpower

29. 8. 2021
The Health and Social Care Secretary Matt Hancock has announced a £37 million investment in genomics projects and data-driven initiatives, which could see patients, including those affected by epilepsy, benefit from better research, treatment, and improved clinical decision-making. ...Read More
Nový projekt

Swiss Life Sciences Group Develops Cannabis Genetics For Healthcare

23. 8. 2021
Swiss Life Sciences Group Plc (SLSG) is pleased to announce its partnership with Switzerland’s leading cannabis and CBDgenetics experts, Bio Zu Farm, who have been developing their own cannabis genetics for more than 25 years. ...Read More
pexels-aphiwat-chuangchoem-2178565-min

CBD and THC: What’s the Difference?

8. 7. 2021
Scientists have identified more than 120 different cannabinoids in the cannabis plant, but the most familiar are THC (delta-9 or delta-8 tetrahydrocannabinol) and CBD (cannabidiol). These two naturally occurring compounds have distinct properties that make them different from one another. ...Read More
pexels-denis-linine-714258-min

Swiss Life Sciences Group Plc Announces Cannabis Technology Investment

10. 5. 2021
Swiss Life Sciences Group Plc is a cannabis-sector private equity company based in London. It has been researching and identifying strategic investments in the fast-growing medical cannabis and phytocannabinoid industry since 2019 and is now focused on developing strategic acquisitions and investments in Switzerland. ...Read More
newsroom_hero

UK’s Largest Seed-to-Consumer CBD Manufacturer to Develop GMP-Certified CBD Facility

18. 4. 2021
Swiss Life Sciences Group Plc is setting its sights on becoming one of the next-generation seed-to-consumer companies in the fast-growing medical cannabis and CBD wellness sectors. ...Read More
Nový projekt(1)

Swiss Life Sciences Group CBD – Disruption Through Transparency

18. 4. 2021
Swiss Life Sciences Group has emerged as one of the largest seed-to-consumer, vertically integrated CBD manufacturers in the European market. Our company aims to provide a transparent and trustworthy network of brands to give consumers peace of mind, in an often unprincipled market. ...Read More